Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin for dysphagia in NSCLC chemoradiotherapy
NCT00094861Phase 2Completed
- Sponsor
- Sobi
- Start
- Jan 2005
- Primary completion
- Dec 2007
- Modality
- Cytokines & Interferons
01
Overview
Phase 2, randomised, double-blind trial in dysphagia comparing Palifermin with Placebo (2 arms). Primary endpoint: Number of Participants With Grade 2 or Higher Dysphagia. Started Jan 2005; status: completed.
02
Drugs
palifermin
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT00094861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00094861.